U.S. drug reviewers have said an investigational eye medicine called VEGF Trap-Eye from Regeneron Pharmaceuticals and Bayer AG is effective against the wet form of age-related macular degeneration, raising expectations it will be recommended for approv…
Category: News
Nearly Half Of All Patients Requiring Vision Correction Are Significantly Astigmatic, Study Shows
Nearly half of patients requiring vision correction are significantly astigmatic in at least one eye, new research shows. Data from the study further reveals that the prevalence of astigmatism is almost double in patients with myopia (nearsightedness) …
UC San Diego Names Robert N. Weinreb Chair Of Ophthalmology
Robert N. Weinreb, MD – a clinician, surgeon and scientist who is internationally renowned for his work with glaucoma – has been selected as the new chair of the department of Ophthalmology and director of the Shiley Eye Center at the University of Cal…
Intravitreal Anti-VEGF Improves Vision In Diabetic Macular Edema Patients
Intravitreal pegaptanib resulted in significantly improved vision in patients with diabetic macular edema, making it an effective, well-tolerated treatment option, a study found.
UC San Diego Names Robert N. Weinreb Chair Of Ophthalmology
Robert N. Weinreb, MD – a clinician, surgeon and scientist who is internationally renowned for his work with glaucoma – has been selected as the new chair of the department of Ophthalmology and director of the Shiley Eye Center at the University of Cal…
UC San Diego Names Robert N. Weinreb Chair Of Ophthalmology
Robert N. Weinreb, MD – a clinician, surgeon and scientist who is internationally renowned for his work with glaucoma – has been selected as the new chair of the department of Ophthalmology and director of the Shiley Eye Center at the University of Cal…
UC San Diego Names Robert N. Weinreb Chair Of Ophthalmology
Robert N. Weinreb, MD – a clinician, surgeon and scientist who is internationally renowned for his work with glaucoma – has been selected as the new chair of the department of Ophthalmology and director of the Shiley Eye Center at the University of Cal…
Single-Piece IOLs May Cause Secondary Glaucoma
Single-piece acrylic IOLs that are malpositioned may cause glaucoma that is often not attributed to the IOL, according to a speaker here.
After 55 Years, Surgery Restores Sight
After being hit in the eye by a stone, a detached retina left a man blind in his right eye. Despite surgery to remove a cataract when the man was 23, which temporarily restored light perception, the patient was completely blind in that eye. Doctors at …
After 55 Years, Surgery Restores Sight
After being hit in the eye by a stone, a detached retina left a man blind in his right eye. Despite surgery to remove a cataract when the man was 23, which temporarily restored light perception, the patient was completely blind in that eye. Doctors at …
Video Interview: Pearls for Ophthalmic Practice Building
Featured Article
Diet Tied To Lower Risk Of Vision Loss In Old Age
For people at a higher risk of losing central vision as they age, eating sufficient levels of certain dietary nutrients could help protect their eyes.
After 55 Years, Surgery Restores Sight
After being hit in the eye by a stone, a detached retina left a man blind in his right eye. Despite surgery to remove a cataract when the man was 23, which temporarily restored light perception, the patient was completely blind in that eye…
Don’t Get Too Hung Up on ‘Meaningful Use’ in an EHR
Although “meaningful use” is a key factor in choosing and using an EHR, other key factors are involved. You could be short-changing yourself if you don’t pay attention to them. Medscape Business of Medicine
Using IPS Cells To Reverse Blindness
Researchers have used cutting-edge stem cell technology to correct a genetic defect present in a rare blinding disorder, another step on a promising path that may one day lead to therapies to reverse blindness caused by common retinal diseases such as …
Children’s Medical Center to open new $21M Specialty Care Center in Southlake
Children’s Medical Center will debut its new Specialty Care Center in Southlake on June 18, a $21 million expansion which will serve children in one of the state’s fastest-growing cities and the surrounding communities.
InNexus files patent protection for new Age-related Macular Degeneration therapeutic
InNexus Biotechnology Inc., a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, announced today that it has filed for patent protection covering a novel antibody produ…
ACT Announces First Patients Enrolled In Two Clinical Trials Using Embryonic Stem Cells To Treat Stargardt’s Disease And Dry Age-Related Macular Degeneration
Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, announced today the enrollment of the first patients in its two Phase 1/2 clinical trials for Stargardt’s Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration …
PSivida Announces Phase I/II Clinical Study Evaluating Bioerodible, Sustained Release Latanoprost Device In Ocular Hypertension And Glaucoma
Drug delivery company pSivida Corp. (NASDAQ: PSDV) (ASX: PVA) today announced the commencement of a Phase I/II clinical trial studying a new bioerodible drug delivery implant for the treatment of glaucoma and ocular hypertension. The implant is designe…
Bazan Assumes Chair Of The ARVO Foundation For Eye Research
Nicolas G. Bazan, MD, PhD, FARVO, of Louisiana State University (LSU) Health Sciences Center in New Orleans, is the new chair of the ARVO Foundation for Eye Research (AFER). He succeeds Gary W. Abrams, MD, FARVO, of Wayne State University/Kresge Eye In…